Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 6/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.63 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.63 |
| ▸ | MET | P08581 | 13/20 | 0.59 |
| ▸ | KDR | P35968 | 6/20 | 0.59 |
| ▸ | AXL | P30530 | 4/20 | 0.59 |
| ▸ | RET | P07949 | 2/20 | 0.59 |
| ▸ | KIT | P10721 | 2/20 | 0.59 |
| ▸ | FLT3 | P36888 | 2/20 | 0.59 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 11/20 | 0.58 |
| ▸ | EGFR | P00533 | 2/20 | 0.54 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.54 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.54 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15917759 | 1.00 | HDAC2 (0.63) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15917251 | 1.00 | HDAC2 (0.63) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15918240 | 1.00 | HDAC2 (0.63) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15918345 | 0.99 | HDAC2 (0.62) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15918338 | 0.99 | HDAC2 (0.62) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15918222 | 0.97 | MET (0.62) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15918320 | 0.97 | MET (0.62) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15917971 | 0.95 | MET (0.57) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15918227 | 0.95 | MET (0.57) | HDAC2HDAC8HDAC6HDAC10HDAC11 | |
| SCHEMBL15916806 | 0.92 | MET (0.55) | HDAC2HDAC8HDAC6HDAC10HDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2769976-B1 | HYDROXAMIC ACID COMPOUND CONTAINING QUINOLYL AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THIS COMPOUND AND USE THEREOF | BEIJING KONRUNS PHARMACEUTICAL CO LTD (CN) | 2017-08-02 | — | — | EP | claimed |
| US-9186318-B2 | Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof | BEIJING KONRUNS PHARMACEUTICAL CO., LTD (CN) | 2015-11-17 | — | — | US | claimed |
| EP-2769976-A1 | HYDROXAMIC ACID COMPOUND CONTAINING QUINOLYL AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THIS COMPOUND AND USE THEREOF | Beijing Konruns Pharmaceutical Co., Ltd. (CN) | 2014-08-27 | — | — | EP | claimed |
| US-20140221425-A1 | Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof | BEIJING KONRUNS PHARMACEUTICAL CO., LTD. (CN) | 2014-08-07 | — | — | US | claimed |
| EP-2769976-B1 | HYDROXAMIC ACID COMPOUND CONTAINING QUINOLYL AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THIS COMPOUND AND USE THEREOF | BEIJING KONRUNS PHARMACEUTICAL CO LTD (CN) | 2017-08-02 | — | — | EP | disclosed |
| US-9186318-B2 | Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof | BEIJING KONRUNS PHARMACEUTICAL CO., LTD (CN) | 2015-11-17 | — | — | US | disclosed |
| EP-2769976-A1 | HYDROXAMIC ACID COMPOUND CONTAINING QUINOLYL AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THIS COMPOUND AND USE THEREOF | Beijing Konruns Pharmaceutical Co., Ltd. (CN) | 2014-08-27 | — | — | EP | disclosed |
| US-20140221425-A1 | Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof | BEIJING KONRUNS PHARMACEUTICAL CO., LTD. (CN) | 2014-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221425-A1 | Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof | HDAC5, HDAC1, HDAC7 | HDAC2 15/4885HDAC8 10/4885HDAC6 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.